MoneyWorks4Me

Natco Pharma informs about compliance report

20 May 2021 Evaluate
Natco Pharma has informed that it enclosed Annual Secretarial Compliance Report for the year ended March 31, 2021, as per Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with SEBI Circular No. CIR/CFD/CMDI/27/2019 dated February 8, 2019 for the year ended March 31, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..